Aducanumab produced a clinically meaningful benefit in association with amyloid lowering.
Article Details
- CitationCopy to clipboard
Cummings J, Aisen P, Lemere C, Atri A, Sabbagh M, Salloway S
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering.
Alzheimers Res Ther. 2021 May 10;13(1):98. doi: 10.1186/s13195-021-00838-z.
- PubMed ID
- 33971962 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs